Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 51

Sort by

Sort Order Select

Meeting Abstracts

775-P: Predictors of Glycemic Control in Older People with Type 2 Diabetes Treated with iGlarLixi—A Pooled Analysis

MEDHA MUNSHI, ROBERT RITZEL, RORY J. MCCRIMMON, IRENE HRAMIAK, FELIPE LAUAND, LYDIE MELAS-MELT, ELISABETH SOUHAMI, JULIO ROSENSTOCK

Diabetes 2023;72(Supplement_1):775-P

https://doi.org/10.2337/db23-775-P

Published: 20 June 2023

View article titled, 775-P: Predictors of Glycemic Control in Older People with Type 2 Diabetes Treated with iGlarLixi—A Pooled Analysis

Meeting Abstracts

243-LB: C5a Receptor (C5aR1) Antagonism Ameliorates Saturated Fatty Acid–Induced Mitochondrial Dysfunction in Skeletal Muscle Cells

DINESH S. SHAH, ALISON D. MCNEILLY, RORY J. MCCRIMMON, HARI HUNDAL

Diabetes 2023;72(Supplement_1):243-LB

https://doi.org/10.2337/db23-243-LB

Published: 20 June 2023

View article titled, 243-LB: C5a Receptor (C5aR1) Antagonism Ameliorates Saturated Fatty Acid–Induced Mitochondrial Dysfunction in Skeletal Muscle Cells

Meeting Abstracts

251-OR: The Impact of Identifying Sleep with a Fitbit on Calculated Rates of Nocturnal Hypoglycemia—The Hypo-Metrics Study

GILBERTE MARTINE-EDITH, PATRICK DIVILLY, NATALIE ZAREMBA, UFFE SOEHOLM, ANDREW KINGSNORTH, ZEINAB MAHMOUDI, MIKEL GOMES, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, ERIC RENARD, SIMON R. HELLER, MARK EVANS, JULIA K. MADER, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, HYPO-RESOLVE CONSORTIUM

Diabetes 2023;72(Supplement_1):251-OR

https://doi.org/10.2337/db23-251-OR

Published: 20 June 2023

View article titled, 251-OR: The Impact of Identifying Sleep with a Fitbit on Calculated Rates of Nocturnal Hypoglycemia—The Hypo-Metrics Study

Meeting Abstracts

250-OR: Majority of Sensor Hypoglycemia Is Not Detected by People Living with Diabetes—Hypo-METRICS Study

PATRICK DIVILLY, GILBERTE MARTINE-EDITH, ZEINAB MAHMOUDI, NATALIE ZAREMBA, UFFE SOEHOLM, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, ERIC RENARD, SIMON R. HELLER, MARK EVANS, JULIA K. MADER, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, HYPO-RESOLVE CONSORTIUM

Diabetes 2023;72(Supplement_1):250-OR

https://doi.org/10.2337/db23-250-OR

Published: 20 June 2023

View article titled, 250-OR: Majority of Sensor Hypoglycemia Is Not Detected by People Living with Diabetes—Hypo-METRICS Study

Meeting Abstracts

392-P: Optimizing Duration and Threshold of Sensor Glucose for Identifying Symptomatic Hypoglycemia in Insulin-Treated Diabetes—Hypo-METRICS Study

PATRICK DIVILLY, ZEINAB MAHMOUDI, GILBERTE MARTINE-EDITH, DIMITRI BOIROUX, NATALIE ZAREMBA, UFFE SOEHOLM, MIKEL GOMES, ALLAN A. VAAG, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, JULIA K. MADER, MARK EVANS, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, HYPO-RESOLVE CONSORTIUM

Diabetes 2023;72(Supplement_1):392-P

https://doi.org/10.2337/db23-392-P

Published: 20 June 2023

View article titled, 392-P: Optimizing Duration and Threshold of Sensor Glucose for Identifying Symptomatic Hypoglycemia in Insulin-Treated Diabetes—Hypo-METRICS Study

Meeting Abstracts

391-P: Individualized Optimization of Duration and Threshold of Sensor Hypoglycemia Improves Identification of Symptomatic Hypoglycemia Episodes—Hypo-METRICS Study

ZEINAB MAHMOUDI, PATRICK DIVILLY, GILBERTE MARTINE-EDITH, DIMITRI BOIROUX, NATALIE ZAREMBA, UFFE SOEHOLM, MIKEL GOMES, ALLAN A. VAAG, JANE SPEIGHT, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, ERIC RENARD, SIMON R. HELLER, MARK EVANS, JULIA K. MADER, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, HYPO-RESOLVE CONSORTIUM

Diabetes 2023;72(Supplement_1):391-P

https://doi.org/10.2337/db23-391-P

Published: 20 June 2023

View article titled, 391-P: Individualized Optimization of Duration and Threshold of Sensor Hypoglycemia Improves Identification of Symptomatic Hypoglycemia Episodes—Hypo-METRICS Study

Meeting Abstracts

388-P: The Impact of Routine CGM on Hypoglycemia Rates and Psychological Outcomes in the Hypo-METRICS Study

NATALIE ZAREMBA, PATRICK DIVILLY, GILBERTE MARTINE-EDITH, ZEINAB MAHMOUDI, UFFE SOEHOLM, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, JULIA K. MADER, MARK EVANS, ERIC RENARD, SIMON R. HELLER, JANE SPEIGHT, STEPHANIE A. AMIEL, PRATIK CHOUDHARY

Diabetes 2023;72(Supplement_1):388-P

https://doi.org/10.2337/db23-388-P

Published: 20 June 2023

View article titled, 388-P: The Impact of Routine CGM on Hypoglycemia Rates and Psychological Outcomes in the Hypo-METRICS Study

Journal Articles

Sustained Proinflammatory Effects of Hypoglycemia in People With Type 2 Diabetes and in People Without Diabetes

Clementine E.M. Verhulst, Julia I.P. van Heck, Therese W. Fabricius, Rinke Stienstra, Steven Teerenstra, Rory J. McCrimmon, Cees J. Tack, Ulrik Pedersen-Bjergaard, Bastiaan E. de Galan

Diabetes 2022;71(12):2716–2727

https://doi.org/10.2337/db22-0246

Published: 18 July 2022

View article titled, Sustained Proinflammatory Effects of Hypoglycemia in People With Type 2 Diabetes and in People Without Diabetes

Meeting Abstracts

711-P: User Acceptability of Ecological Momentary Assessment to Report Hypoglycemia over Ten Weeks Using a Novel Smartphone Application in the Hypo-METRICS Study: Hypoglycemia Measurements, Thresholds and Impacts

NATALIE ZAREMBA, GILBERTE MARTINE-EDITH, PATRICK DIVILLY, ZEINAB MAHMOUDI, UFFE SOEHOLM, MELANIE M. BROADLEY, FRANS POUWER, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, ERIC RENARD, SIMON R. HELLER, MARK EVANS, JULIA K. MADER, ALEXANDER SEIBOLD, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, HYPO-RESOLVE CONSORTIUM

Diabetes 2022;71(Supplement_1):711-P

https://doi.org/10.2337/db22-711-P

Published: 01 June 2022

View article titled, 711-P: User Acceptability of Ecological Momentary Assessment to Report Hypoglycemia over Ten Weeks Using a Novel Smartphone Application in the Hypo-METRICS Study: Hypoglycemia Measurements, Thresholds and Impacts

Meeting Abstracts

233-OR: Impact of Nocturnal Hypoglycemia on Daily Sleep Quality, Mood, and Alertness among Adults with Type 1 Diabetes: The Hypo-METRICS (Hypoglycaemia Measurement, Thresholds, and Impacts) Study

Diabetes 2022;71(Supplement_1):233-OR

https://doi.org/10.2337/db22-233-OR

Published: 01 June 2022

View article titled, 233-OR: Impact of Nocturnal Hypoglycemia on Daily Sleep Quality, Mood, and Alertness among Adults with Type 1 Diabetes: The Hypo-METRICS (Hypoglycaemia Measurement, Thresholds, and Impacts) Study

Meeting Abstracts

260-OR: iGlarLixi vs. Basal plus Rapid-Acting Insulin in Adults with Type 2 Diabetes Advancing from Basal Insulin Therapy: The SoliSimplify Real-World Study

RORY J. MCCRIMMON, ALICE Y. CHENG, GAGIK R. GALSTYAN, KHIER DJABALLAH, XUAN LI, MATHIEU COUDERT, JUAN PABLO FRIAS

Diabetes 2022;71(Supplement_1):260-OR

https://doi.org/10.2337/db22-260-OR

Published: 01 June 2022

View article titled, 260-OR: iGlarLixi vs. Basal plus Rapid-Acting Insulin in Adults with Type 2 Diabetes Advancing from Basal Insulin Therapy: The SoliSimplify Real-World Study

Meeting Abstracts

833-P: Impact of Hypoglycemia on Insulin Titration and Fasting Plasma Glucose in Basal Insulin–Treated Type 2 Diabetes: A Subanalysis of the SoliMix Trial

FRANCESCO GIORGINO, JULIO ROSENSTOCK, ROBERT RITZEL, OGUZHAN DEYNELI, AGUSTINA ALVAREZ, ELISABETH SOUHAMI, LYDIE MELAS-MELT, RORY J. MCCRIMMON

Diabetes 2022;71(Supplement_1):833-P

https://doi.org/10.2337/db22-833-P

Published: 01 June 2022

View article titled, 833-P: Impact of Hypoglycemia on Insulin Titration and Fasting Plasma Glucose in Basal Insulin–Treated Type 2 Diabetes: A Subanalysis of the SoliMix Trial

Meeting Abstracts

689-P: Comparing the Rates of Sensor-Detected Hypoglycaemia and Patient-Reported Hypoglycaemia by Awareness of Hypoglycaemia Using Continuous Glucose Monitoring: The Hypo-METRICS Trial

PATRICK DIVILLY, GILBERTE MARTINE-EDITH, ZEINAB MAHMOUDI, NATALIE ZAREMBA, UFFE SOEHOLM, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, BASTIAAN E. DE GALAN, ERIC RENARD, SIMON R. HELLER, MARK EVANS, JULIA K. MADER, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, ALEXANDER SEIBOLD

Diabetes 2022;71(Supplement_1):689-P

https://doi.org/10.2337/db22-689-P

Published: 01 June 2022

View article titled, 689-P: Comparing the Rates of Sensor-Detected Hypoglycaemia and Patient-Reported Hypoglycaemia by Awareness of Hypoglycaemia Using Continuous Glucose Monitoring: The Hypo-METRICS Trial

Meeting Abstracts

688-P: Comparing Rates of Sensor-Detected Hypoglycaemia and Patient-Reported Hypoglycaemia by Method of Glucose Monitoring: The Hypo-METRICS Trial

PATRICK DIVILLY, GILBERTE MARTINE-EDITH, ZEINAB MAHMOUDI, NATALIE ZAREMBA, UFFE SOEHOLM, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, ERIC RENARD, SIMON R. HELLER, MARK EVANS, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, ALEXANDER SEIBOLD

Diabetes 2022;71(Supplement_1):688-P

https://doi.org/10.2337/db22-688-P

Published: 01 June 2022

View article titled, 688-P: Comparing Rates of Sensor-Detected Hypoglycaemia and Patient-Reported Hypoglycaemia by Method of Glucose Monitoring: The Hypo-METRICS Trial

Meeting Abstracts

846-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline Age, Diabetes Duration, and Renal Function

PHILIP HOME, JULIO ROSENSTOCK, FRANCESCO GIORGINO, MATTHIAS BLÜHER, KHIER DJABALLAH, KATRIN PEGELOW, LYDIE MELAS-MELT, RORY J. MCCRIMMON

Diabetes 2022;71(Supplement_1):846-P

https://doi.org/10.2337/db22-846-P

Published: 01 June 2022

View article titled, 846-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline Age, Diabetes Duration, and Renal Function

Meeting Abstracts

845-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline HbA1c, Insulin Dose, and BMI

PHILIP HOME, RORY J. MCCRIMMON, JULIO ROSENSTOCK, MATTHIAS BLÜHER, KATRIN PEGELOW, LYDIE MELAS-MELT, KHIER DJABALLAH, FRANCESCO GIORGINO

Diabetes 2022;71(Supplement_1):845-P

https://doi.org/10.2337/db22-845-P

Published: 01 June 2022

View article titled, 845-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline HbA1c, Insulin Dose, and BMI

Meeting Abstracts

373-P: A Systematic Review and Meta-analysis of the Impact of Acute Hypoglycemia on Cognitive Function in Adults with Type 1 Diabetes

MELANIE M. BROADLEY, HANNAH CHATWIN, UFFE SOEHOLM, JOHANNE AXELSEN, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, BASTIAAN E. DE GALAN, THERESE W. FABRICIUS, SIMON R. HELLER, CHRISTEL HENDRIECKX, RORY J. MCCRIMMON, GIESJE NEFS, ULRIK PEDERSEN-BJERGAARD, CLEMENTINE E. VERHULST, JANE SPEIGHT, FRANS POUWER, THE HYPO-RESOLVE CONSORTIUM

Diabetes 2022;71(Supplement_1):373-P

https://doi.org/10.2337/db22-373-P

Published: 01 June 2022

View article titled, 373-P: A Systematic Review and Meta-analysis of the Impact of Acute Hypoglycemia on Cognitive Function in Adults with Type 1 Diabetes

Meeting Abstracts

234-OR: Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Better Clinical Outcomes with IGlarLixi vs. Premix 70/30 in the SoliMix Trial

JULIO ROSENSTOCK, RIFAT EMRAL, LEOBARDO SAUQUE-REYNA, VISWANATHAN MOHAN, CARLOS TRESCOLI, SAUD N. AL SIFRI, NEBOJSA LALIC, AGUSTINA ALVAREZ, PASCALINE PICARD, NACIMA DEMIL, MIREILLE BONNEMAIRE, RORY J. MCCRIMMON

Diabetes 2021;70(Supplement_1):234-OR

https://doi.org/10.2337/db21-234-OR

Published: 01 June 2021

View article titled, 234-OR: Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Better Clinical Outcomes with IGlarLixi vs. Premix 70/30 in the SoliMix Trial

Meeting Abstracts

748-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial in Participants in Europe

ALICE Y. CHENG, RORY J. MCCRIMMON, VIVIAN FONSECA, CARLOS TRESCOLI, MARTIN HALUZIK, JOCHEN SEUFERT, AGUSTINA ALVAREZ, ELISABETH SOUHAMI, PASCALINE PICARD, MIREILLE BONNEMAIRE, JULIO ROSENSTOCK

Diabetes 2021;70(Supplement_1):748-P

https://doi.org/10.2337/db21-748-P

Published: 01 June 2021

View article titled, 748-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial in Participants in Europe

Meeting Abstracts

749-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial Outside Europe

VIVIAN FONSECA, JULIO ROSENSTOCK, ALICE Y. CHENG, RIFAT EMRAL, LEOBARDO SAUQUE-REYNA, VISWANATHAN MOHAN, SAUD N. AL SIFRI, AGUSTINA ALVAREZ, KHIER DJABALLAH, PASCALINE PICARD, ELISABETH SOUHAMI, RORY J. MCCRIMMON

Diabetes 2021;70(Supplement_1):749-P

https://doi.org/10.2337/db21-749-P

Published: 01 June 2021

View article titled, 749-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial Outside Europe

NARROW

775-P: Predictors of Glycemic Control in Older People with Type 2 Diabetes Treated with iGlarLixi—A Pooled Analysis

243-LB: C5a Receptor (C5aR1) Antagonism Ameliorates Saturated Fatty Acid–Induced Mitochondrial Dysfunction in Skeletal Muscle Cells

251-OR: The Impact of Identifying Sleep with a Fitbit on Calculated Rates of Nocturnal Hypoglycemia—The Hypo-Metrics Study

250-OR: Majority of Sensor Hypoglycemia Is Not Detected by People Living with Diabetes—Hypo-METRICS Study

392-P: Optimizing Duration and Threshold of Sensor Glucose for Identifying Symptomatic Hypoglycemia in Insulin-Treated Diabetes—Hypo-METRICS Study

391-P: Individualized Optimization of Duration and Threshold of Sensor Hypoglycemia Improves Identification of Symptomatic Hypoglycemia Episodes—Hypo-METRICS Study

388-P: The Impact of Routine CGM on Hypoglycemia Rates and Psychological Outcomes in the Hypo-METRICS Study

Sustained Proinflammatory Effects of Hypoglycemia in People With Type 2 Diabetes and in People Without Diabetes

711-P: User Acceptability of Ecological Momentary Assessment to Report Hypoglycemia over Ten Weeks Using a Novel Smartphone Application in the Hypo-METRICS Study: Hypoglycemia Measurements, Thresholds and Impacts

233-OR: Impact of Nocturnal Hypoglycemia on Daily Sleep Quality, Mood, and Alertness among Adults with Type 1 Diabetes: The Hypo-METRICS (Hypoglycaemia Measurement, Thresholds, and Impacts) Study

260-OR: iGlarLixi vs. Basal plus Rapid-Acting Insulin in Adults with Type 2 Diabetes Advancing from Basal Insulin Therapy: The SoliSimplify Real-World Study

833-P: Impact of Hypoglycemia on Insulin Titration and Fasting Plasma Glucose in Basal Insulin–Treated Type 2 Diabetes: A Subanalysis of the SoliMix Trial

689-P: Comparing the Rates of Sensor-Detected Hypoglycaemia and Patient-Reported Hypoglycaemia by Awareness of Hypoglycaemia Using Continuous Glucose Monitoring: The Hypo-METRICS Trial

688-P: Comparing Rates of Sensor-Detected Hypoglycaemia and Patient-Reported Hypoglycaemia by Method of Glucose Monitoring: The Hypo-METRICS Trial

846-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline Age, Diabetes Duration, and Renal Function

845-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline HbA1c, Insulin Dose, and BMI

373-P: A Systematic Review and Meta-analysis of the Impact of Acute Hypoglycemia on Cognitive Function in Adults with Type 1 Diabetes

234-OR: Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Better Clinical Outcomes with IGlarLixi vs. Premix 70/30 in the SoliMix Trial

748-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial in Participants in Europe

749-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial Outside Europe

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only